NORATIS AG (NUVA.DE) Fundamental Analysis & Valuation

FRA:NUVA • DE000A2E4MK4

0.181 EUR
-0.02 (-9.5%)
Last: Mar 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This NUVA.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, NUVA scores 3 out of 10 in our fundamental rating. NUVA was compared to 73 industry peers in the Real Estate Management & Development industry. NUVA has a bad profitability rating. Also its financial health evaluation is rather negative. NUVA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. NUVA.DE Profitability Analysis

1.1 Basic Checks

  • In the past year NUVA has reported negative net income.
  • NUVA had a positive operating cash flow in the past year.
  • In multiple years NUVA reported negative net income over the last 5 years.
  • In multiple years NUVA reported negative operating cash flow during the last 5 years.
NUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFNUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • NUVA's Return On Assets of -5.16% is on the low side compared to the rest of the industry. NUVA is outperformed by 68.49% of its industry peers.
  • NUVA's Return On Equity of -38.04% is on the low side compared to the rest of the industry. NUVA is outperformed by 75.34% of its industry peers.
  • The Return On Invested Capital of NUVA (0.71%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NUVA is below the industry average of 4.07%.
Industry RankSector Rank
ROA -5.16%
ROE -38.04%
ROIC 0.71%
ROA(3y)-2.47%
ROA(5y)-0.91%
ROE(3y)-16.73%
ROE(5y)-6.94%
ROIC(3y)1.9%
ROIC(5y)2.12%
NUVA.DE Yearly ROA, ROE, ROICNUVA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

1.3 Margins

  • NUVA has a Operating Margin (4.65%) which is comparable to the rest of the industry.
  • NUVA's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 17.76%, NUVA perfoms like the industry average, outperforming 42.47% of the companies in the same industry.
  • NUVA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.65%
PM (TTM) N/A
GM 17.76%
OM growth 3Y-20.54%
OM growth 5Y-12.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.05%
GM growth 5Y-6.76%
NUVA.DE Yearly Profit, Operating, Gross MarginsNUVA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NUVA.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUVA is destroying value.
  • Compared to 1 year ago, NUVA has more shares outstanding
  • NUVA has more shares outstanding than it did 5 years ago.
  • NUVA has a worse debt/assets ratio than last year.
NUVA.DE Yearly Shares OutstandingNUVA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NUVA.DE Yearly Total Debt VS Total AssetsNUVA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • NUVA has an Altman-Z score of 1.02. This is a bad value and indicates that NUVA is not financially healthy and even has some risk of bankruptcy.
  • NUVA has a Altman-Z score (1.02) which is comparable to the rest of the industry.
  • NUVA has a debt to FCF ratio of 9.27. This is a negative value and a sign of low solvency as NUVA would need 9.27 years to pay back of all of its debts.
  • NUVA's Debt to FCF ratio of 9.27 is fine compared to the rest of the industry. NUVA outperforms 75.34% of its industry peers.
  • NUVA has a Debt/Equity ratio of 4.80. This is a high value indicating a heavy dependency on external financing.
  • NUVA's Debt to Equity ratio of 4.80 is on the low side compared to the rest of the industry. NUVA is outperformed by 82.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.8
Debt/FCF 9.27
Altman-Z 1.02
ROIC/WACC0.21
WACC3.36%
NUVA.DE Yearly LT Debt VS Equity VS FCFNUVA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • NUVA has a Current Ratio of 4.49. This indicates that NUVA is financially healthy and has no problem in meeting its short term obligations.
  • NUVA has a Current ratio of 4.49. This is amongst the best in the industry. NUVA outperforms 86.30% of its industry peers.
  • NUVA has a Quick Ratio of 4.49. This is a bad value and indicates that NUVA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NUVA has a Quick ratio of 0.19. This is amonst the worse of the industry: NUVA underperforms 80.82% of its industry peers.
Industry RankSector Rank
Current Ratio 4.49
Quick Ratio 0.19
NUVA.DE Yearly Current Assets VS Current LiabilitesNUVA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NUVA.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 52.39% over the past year.
  • NUVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.83%.
  • The Revenue has been decreasing by -2.61% on average over the past years.
EPS 1Y (TTM)52.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.45%
Revenue 1Y (TTM)43.83%
Revenue growth 3Y-3.3%
Revenue growth 5Y-2.61%
Sales Q2Q%8.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.62% on average over the next years. This is quite good.
  • Based on estimates for the next years, NUVA will show a quite strong growth in Revenue. The Revenue will grow by 8.98% on average per year.
EPS Next Y48.11%
EPS Next 2Y41.51%
EPS Next 3Y26.7%
EPS Next 5Y15.62%
Revenue Next Year-29.11%
Revenue Next 2Y8.43%
Revenue Next 3Y10.31%
Revenue Next 5Y8.98%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NUVA.DE Yearly Revenue VS EstimatesNUVA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
NUVA.DE Yearly EPS VS EstimatesNUVA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

5

4. NUVA.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • NUVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • NUVA is valuated rather expensively with a Price/Forward Earnings ratio of 17.75.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NUVA indicates a somewhat cheap valuation: NUVA is cheaper than 65.75% of the companies listed in the same industry.
  • NUVA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.57.
Industry RankSector Rank
PE N/A
Fwd PE 17.75
NUVA.DE Price Earnings VS Forward Price EarningsNUVA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • NUVA's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 100.00% of the companies in the same industry are more expensive than NUVA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.07
EV/EBITDA 92.58
NUVA.DE Per share dataNUVA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NUVA's earnings are expected to grow with 26.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.51%
EPS Next 3Y26.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NUVA.DE Dividend Analysis

5.1 Amount

  • NUVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NUVA.DE Fundamentals: All Metrics, Ratios and Statistics

NORATIS AG

FRA:NUVA (3/5/2026, 7:00:00 PM)

0.181

-0.02 (-9.5%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-02
Earnings (Next)07-09
Inst Owners0.22%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap2.46M
Revenue(TTM)68.25M
Net Income(TTM)-20.73M
Analysts42.22
Price Target1.12 (518.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-147.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.75
P/S 0.04
P/FCF 0.07
P/OCF 0.07
P/B 0.05
P/tB 0.05
EV/EBITDA 92.58
EPS(TTM)-2.02
EYN/A
EPS(NY)0.01
Fwd EY5.64%
FCF(TTM)2.74
FCFY1513.09%
OCF(TTM)2.74
OCFY1512.92%
SpS5.03
BVpS4.01
TBVpS4.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.16%
ROE -38.04%
ROCE 1.01%
ROIC 0.71%
ROICexc 0.73%
ROICexgc 0.73%
OM 4.65%
PM (TTM) N/A
GM 17.76%
FCFM 54.45%
ROA(3y)-2.47%
ROA(5y)-0.91%
ROE(3y)-16.73%
ROE(5y)-6.94%
ROIC(3y)1.9%
ROIC(5y)2.12%
ROICexc(3y)1.95%
ROICexc(5y)2.2%
ROICexgc(3y)1.95%
ROICexgc(5y)2.2%
ROCE(3y)2.69%
ROCE(5y)3.01%
ROICexgc growth 3Y-26.63%
ROICexgc growth 5Y-23.14%
ROICexc growth 3Y-26.63%
ROICexc growth 5Y-23.14%
OM growth 3Y-20.54%
OM growth 5Y-12.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.05%
GM growth 5Y-6.76%
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 4.8
Debt/FCF 9.27
Debt/EBITDA 71.8
Cap/Depr 0.86%
Cap/Sales 0.01%
Interest Coverage 0.22
Cash Conversion 1020.6%
Profit Quality N/A
Current Ratio 4.49
Quick Ratio 0.19
Altman-Z 1.02
F-Score5
WACC3.36%
ROIC/WACC0.21
Cap/Depr(3y)14.01%
Cap/Depr(5y)16.5%
Cap/Sales(3y)0.08%
Cap/Sales(5y)0.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.45%
EPS Next Y48.11%
EPS Next 2Y41.51%
EPS Next 3Y26.7%
EPS Next 5Y15.62%
Revenue 1Y (TTM)43.83%
Revenue growth 3Y-3.3%
Revenue growth 5Y-2.61%
Sales Q2Q%8.18%
Revenue Next Year-29.11%
Revenue Next 2Y8.43%
Revenue Next 3Y10.31%
Revenue Next 5Y8.98%
EBIT growth 1Y-44.77%
EBIT growth 3Y-23.16%
EBIT growth 5Y-14.59%
EBIT Next Year118.69%
EBIT Next 3Y38.46%
EBIT Next 5Y23.33%
FCF growth 1Y224.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y225.46%
OCF growth 3YN/A
OCF growth 5YN/A

NORATIS AG / NUVA.DE FAQ

What is the fundamental rating for NUVA stock?

ChartMill assigns a fundamental rating of 3 / 10 to NUVA.DE.


What is the valuation status for NUVA stock?

ChartMill assigns a valuation rating of 5 / 10 to NORATIS AG (NUVA.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for NORATIS AG?

NORATIS AG (NUVA.DE) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for NUVA stock?

The Earnings per Share (EPS) of NORATIS AG (NUVA.DE) is expected to grow by 48.11% in the next year.